Clinical Trial Update: Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports the termination of a study comparing three regimens in previously untreated Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Lymphoma | Phase 3 | Status: TERMINATED